www.newsmax.com
FDA: Novo Nordisk's Obesity Pill Ad Is Misleading
The Food and Drug Administration has warned Novo Nordisk that a television advertisement promoting its newly launched Wegovy pill for obesity contains "false or misleading" claims, saying the spot misbrands the drug and violates federal law, CNBC reported Monday.
New Posts (Home)
ChatBox
Popular Posts 
Game Zone
Top PodCasts
